Home › Cardiovascular Disease › Arizona › Gilbert
Cardiovascular Disease clinical trials in Gilbert, AZ
6 studies for Cardiovascular Disease are looking for participants at sites in and around Gilbert (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Gilbert
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Mercy Gilbert Medical Center, Gilbert
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Gilbert
- Research Site, Gilbert
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Recruiting
- Dignity Health - Mercy Gilbert Medical Center, Gilbert
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Dignity Health - Mercy Gilbert Medical Center, Gilbert
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Gilbert
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer9 studies
- Lung Cancer8 studies
- Cancer (all types)8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Metastatic Cancer6 studies
- Multiple Myeloma6 studies
- Heart Failure6 studies
- Bladder Cancer6 studies
- Non-Hodgkin Lymphoma5 studies
- Diffuse Large B-Cell Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.